Episode
Episode 454: Managing MS-Related Depression with Dr. Anthony Feinstein
- Podcast
- RealTalk MS
- Published
- May 11, 2026
- Duration seconds
- 1803
- Processing state
not_requested- Canonical source
- https://realtalkms.com/454
Actions
POST https://stenobird.com/v1/public/podcasts/realtalk-ms-779631/episodes/episode-454-managing-ms-related-depression-with-dr-anthony-feinstein/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/realtalk-ms-779631/episode-454-managing-ms-related-depression-with-dr-anthony-feinstein.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
One out of every two people with MS will experience clinical depression at some point in their MS journey, making depression one of the most significant yet under-discussed aspects of living with MS. While the physical symptoms of MS often take center stage, the neuropsychiatric challenges can be just as impactful on an individual's overall quality of life and long-term outcomes. Joining us to shed some light on this important topic is Dr. Anthony Feinstein, a world-renowned neuropsychiatrist and professor at the University of Toronto. Dr. Feinstein has spent decades researching the biological and psychological drivers of depression in MS. We're also sharing study results revealing that wait times to see a neurologist in the U.S. are way too long. We'll tell you about a pilot trial that's recruiting participants for an implantable device designed to promote remyelination. We're just two days away from the National MS Society's webcast on protecting federal funding for MS research, the NIH, CDC, and FDA. We're sharing all the details and info to register. And we'll tell you all about the MS Society's statement for the record at a congressional hearing, exposing how Pharmacy Benefit Managers often prioritize profits over patient welfare. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: Managing MS-Related Depression :22 Study results reveal wait times for an appointment with a neurologist in the U.S. 1:45 A pilot clinical trial for an implantable device designed to promote remyelination 4:38 A webcast to update you on the National MS Society's advocacy efforts to protect federal funding for MS research, the NIH, CDC, and FDA 7:05 The National MS Society has submitted a critical statement for the record at a congressional hearing, exposing how Phar…